088350:KRXHanwha Life Insurance Co., Ltd. Analysis
Data as of 2026-03-07 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Hanwha Life Insurance is trading at KRW 4,950, comfortably above its 20‑day SMA of 4,644 and 50‑day SMA of 3,825, indicating a short‑term bullish bias. The RSI sits at 56, suggesting momentum is still neutral‑to‑positive, while the MACD histogram is negative, flagging a potential near‑term bearish cross. Volume is on an increasing trend, supporting the price advance, but the 30‑day volatility of 122% and a beta of only 0.33 highlight a stock that can swing sharply despite low market‑wide correlation. Fundamentally, the forward PE of 5.15 is well below the industry average of 17.46, pointing to a valuation gap, yet free cash flow is deeply negative (‑KRW 9.2 trillion) and debt‑to‑equity stands at a high 126%, raising concerns about capital efficiency. The company’s revenue growth of 5.1% and a modest operating margin of 0.4% suggest limited upside from earnings expansion. No dividend is paid, eliminating income‑focused appeal. Overall, the blend of a cheap valuation, strong short‑term price support, and elevated risk factors creates a nuanced investment picture.
Market Outlook
Short Term
< 1 yearKey Factors
- Price above 20‑day and 50‑day SMAs
- Bearish MACD histogram
- High 30‑day volatility
Medium Term
1–3 yearsKey Factors
- Forward PE far below industry average
- Increasing trading volume
- Revenue growth of 5% supporting earnings potential
Long Term
> 3 yearsKey Factors
- Low beta indicating defensive profile
- Strong balance‑sheet cash reserves despite debt
- Stable insurance sector with demographic tailwinds
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.